Cargando...
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable...
Gardado en:
| Publicado en: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935656/ https://ncbi.nlm.nih.gov/pubmed/31893063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2496 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|